2022 annual financial data

Ironwood Pharmaceuticals 2022 Financial results

Direct answer

Revenue was 410,596,000 USD.

Operating income was 250,337,000 USD and net income was 175,065,000 USD.
Operating cash flow was 273,763,000 USD.

Get free Ironwood Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
410,596,000 USD
Operating income
250,337,000 USD
Net income
175,065,000 USD
Operating cash flow
273,763,000 USD